The purpose of this online quiz is to challenge your knowledge and understanding of the concepts that underpin pathophysiology and pharmacology, the pharmacology principles of nursing, the use of analgesics and anti-inflammatory medications, and blood disorders and their associated medications such as anticoagulant and anti-platelet therapies.

Online quiz details:

• Opens: Week 5, Monday at 10:00 am AEST (QLD time).
• Closes: Week 5, Tuesday at 10.00 am AEST (QLD time).
• Topics examined: Weeks 1 to 4 inclusive.
• Attempts allowed: One (1).
• In the absence of an approved extension request, there will be no opportunity to complete the task after the assigned date.
   

Level of GenAI use allowed:

Level 1: You must not use AI at any point during the assessment. You must demonstrate your core skills and knowledge.

The 72- hour grace period does not apply to this assessment.

1. A variety of question styles similar to those used in the weekly practice quizzes, as well as application questions, will be used to assess the unit content in a variety of contexts.
2. All late submissions will be penalised 5% per calendar day unless an extension request for more time has been approved. 

Aim

The aim of this assessment is to consolidate your learning and demonstrate your understanding of how a disease or condition affects a patient. To do this, you will apply the theory you have learned to a patient scenario presented in a case study. This assessment is designed to help you develop the level of understanding needed to provide evidence-based advice within your scope of practice, enabling you to manage and educate patients while addressing gaps in healthcare.

This requirements of this assessment includes:

• Demonstrating an understanding of the aetiology, risk factors, and pathophysiology of the disease or condition that your patient has.
• Demonstrating an understanding of the clinical manifestations exhibited by your patient. 
• Demonstrating an understanding of the diagnostic tests conducted on your patient. 
• Demonstrating an understanding of the medication provided to your patient to treat their disease or manage their clinical manifestations. 
• Demonstrating an understanding of the nursing approaches surrounding patient care. 

Completion of the case study

• The case study will be presented in an online format with various question styles used to assess your understanding of the disease or condition.
• Case study topics will focus on diseases or conditions covered in Weeks 4–12 of this unit, and may also incorporate relevant foundational concepts and nursing practices introduced in Weeks 1–3.
• Throughout the online case study, you will be provided with information on the patient’s clinical presentation, history, and physical examination findings. As you progress, you will be required to answer questions based on this information. These questions are designed to assess your ability to apply the knowledge you have developed over the term to the patient scenario.
   

Question style

• The case study will have a combination of question styles including multiple choice, multiple selection, short answer and long answer questions.
• A maximum word count will be specified for written-answer questions.
  • Short-answer questions may only require a few words.
  • Longer written responses will include an approximate word count to guide you in answering effectively.
• Each question will include information about the patient; however, some may also require details from earlier sections. Therefore, it is recommended that you take notes on your patient as you progress through the case study.
   

Referencing

• Some written-answer questions may require you to include an appropriate reference.
• If a reference is required for your written answer, this will be indicated in the question. In such cases, you must identify the source of your information.
• Only the resources listed below and provided on Moodle are to be used:
  • Approved resources:
    • The prescribed textbook for BIOH28001.
    • BIOH28001 lecture and tutorial slides relevant to your topic.
    • Any resources from the BIOH28001 E-reading list relevant to your topic (e.g., textbooks, journal articles, MIMS).
  • Referencing Requirements:
    • Your reference should be placed on a new line after your answer and must clearly state which approved resource you used.
    • As this is a timed assessment, you only need to identify the approved resource (e.g., Week 5 Lecture OR Pathophysiology and Pharmacology for Nurses 1 OR MIMS).
    • In-text referencing is not required.

Level of Gen AI allowed:
Level 1: You must not use AI at any point during the assessment. You must demonstrate your core skills and knowledge.

The 72-hour grace period does not apply to this assessment.

1. The online clinical case study will include a combination of automatically and manually marked questions.
2. All late submissions will incur a penalty of 5% per calendar day or part thereof unless an extension has been approved. 
   
   
   

The purpose of this online test is to assess your understanding of the pathophysiology and pharmacology of the cardiovascular, respiratory, endocrine, and neurological systems as covered in this unit.

• Online test details:
  • Opens: Week 12, Thursday 12th February at 10:00 am AEST.
  • Closes: Week 12 Friday 13th February at 10:00 am AEST.
  • Topics examined: Weeks 5 to 12.
  • Attempts allowed: One (1).
  • In the absence of an approved extension, the task cannot be completed after the designated due date.

Level of GenAI allowed:

Level 1: You must not use AI at any point during the assessment. You must demonstrate your core skills and knowledge.

The 72-hour grace period does not apply to this assessment

1. The online test will consist of both automatically and manually marked questions.
2. A variety of question styles, similar to those used in the weekly practice quizzes, as well as case study questions, will be employed to assess unit content across diverse contexts.
3. Late submissions will incur a penalty of 5% per calendar day unless an extension has been approved.